Drug name
Last update: Aug 2026MK-8591B (islatravir + ulonivirine)
Developer(s)
Drug information
Not provided
Not provided
Not provided
Small molecule
NRTTI+NNRTI
Not provided
Unknown
Unknown
Therapeutic area(s)
- HIV
- Treatment
Administration route
Oral
Associated long-acting platforms
Oral solid form
Use of drug
- Self-administered
Not provided
Dosage
Not provided
Not provided
Not provided
Not provided
Not provided
Associated compounds, formulations and regimens
Islatravir (ISL)
Ulonivirine (MK-8507)
Associated technologies
Not provided
Additional information
Developer(s)
Merck / MSD
Drug structure
Scale-up and manufacturing prospects
Not provided
Not provided
Not provided
Not provided
Excipients & delivery device(s)
Not provided
Not provided
Not provided
No delivery device
Safety, Efficacy and Evidence Summary
Not provided
Not provided
Not provided
Not provided